MDLN vs. PHG
Compare and contrast key facts about Medline Inc (MDLN) and Koninklijke Philips N.V. (PHG).
Performance
MDLN vs. PHG - Performance Comparison
Loading graphics...
MDLN vs. PHG - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
MDLN Medline Inc | 4.76% | 2.44% |
PHG Koninklijke Philips N.V. | 0.78% | 3.64% |
Fundamentals
MDLN:
$35.73B
PHG:
$26.36B
MDLN:
$1.45
PHG:
$0.93
MDLN:
30.25
PHG:
29.34
MDLN:
0.15
PHG:
15.23
MDLN:
1.23
PHG:
1.47
MDLN:
3.33
PHG:
2.41
MDLN:
$28.43B
PHG:
$17.83B
MDLN:
$6.99B
PHG:
$8.06B
MDLN:
$3.11B
PHG:
$2.60B
Returns By Period
In the year-to-date period, MDLN achieves a 4.76% return, which is significantly higher than PHG's 0.78% return.
MDLN
- 1D
- -1.12%
- 1M
- -4.03%
- YTD
- 4.76%
- 6M
- —
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
PHG
- 1D
- -0.40%
- 1M
- -12.42%
- YTD
- 0.78%
- 6M
- -1.27%
- 1Y
- 12.13%
- 3Y*
- 15.52%
- 5Y*
- -12.42%
- 10Y*
- 1.62%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
MDLN vs. PHG — Risk / Return Rank
MDLN
PHG
MDLN vs. PHG - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Medline Inc (MDLN) and Koninklijke Philips N.V. (PHG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
Loading graphics...
Sharpe Ratios by Period
| MDLN | PHG | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | — | 0.37 | — |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | -0.33 | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.05 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.70 | 0.20 | +0.50 |
Correlation
The correlation between MDLN and PHG is 0.16, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
MDLN vs. PHG - Dividend Comparison
MDLN has not paid dividends to shareholders, while PHG's dividend yield for the trailing twelve months is around 3.25%.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
MDLN Medline Inc | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
PHG Koninklijke Philips N.V. | 3.25% | 3.27% | 0.00% | 0.00% | 6.43% | 2.80% | 0.00% | 1.97% | 2.82% | 2.02% | 2.51% | 2.98% |
Drawdowns
MDLN vs. PHG - Drawdown Comparison
The maximum MDLN drawdown since its inception was -17.84%, smaller than the maximum PHG drawdown of -79.61%. Use the drawdown chart below to compare losses from any high point for MDLN and PHG.
Loading graphics...
Drawdown Indicators
| MDLN | PHG | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -17.84% | -79.61% | +61.77% |
Max Drawdown (1Y)Largest decline over 1 year | — | -20.24% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -79.61% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -79.61% | — |
Current DrawdownCurrent decline from peak | -11.98% | -50.92% | +38.94% |
Average DrawdownAverage peak-to-trough decline | -6.72% | -29.13% | +22.41% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | — | 6.60% | — |
Volatility
MDLN vs. PHG - Volatility Comparison
Loading graphics...
Volatility by Period
| MDLN | PHG | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | — | 9.33% | — |
Volatility (6M)Calculated over the trailing 6-month period | — | 21.44% | — |
Volatility (1Y)Calculated over the trailing 1-year period | 40.87% | 32.51% | +8.36% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 40.87% | 37.34% | +3.53% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 40.87% | 31.91% | +8.96% |
Financials
MDLN vs. PHG - Financials Comparison
This section allows you to compare key financial metrics between Medline Inc and Koninklijke Philips N.V.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
MDLN vs. PHG - Profitability Comparison
MDLN - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Medline Inc reported a gross profit of 1.91B and revenue of 7.79B. Therefore, the gross margin over that period was 24.6%.
PHG - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Koninklijke Philips N.V. reported a gross profit of 2.29B and revenue of 5.10B. Therefore, the gross margin over that period was 44.9%.
MDLN - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Medline Inc reported an operating income of 425.00M and revenue of 7.79B, resulting in an operating margin of 5.5%.
PHG - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Koninklijke Philips N.V. reported an operating income of 540.00M and revenue of 5.10B, resulting in an operating margin of 10.6%.
MDLN - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Medline Inc reported a net income of 180.00M and revenue of 7.79B, resulting in a net margin of 2.3%.
PHG - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Koninklijke Philips N.V. reported a net income of 395.00M and revenue of 5.10B, resulting in a net margin of 7.8%.